© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Umeclidinium Bromide belongs to a class of synthetic compounds known for their role in managing chronic respiratory conditions. This chemical appears as a solid, generally taking the form of a fine white powder, with occasional variability toward off-white or pale hues depending on purity and production batch techniques. It dissolves efficiently in water, forming a clear solution, which aids its application in medicinal formulations. Umeclidinium Bromide features a molecular formula of C29H34BrNO2 and a molecular weight of 508.49 g/mol, clearly showing the compound’s complex, large-molecule structure. This substance demonstrates a density of approximately 1.3 g/cm3, and the compound remains stable under typical environmental conditions, resisting breakdown from light and moderate temperature swings during handling and storage.
Structurally, Umeclidinium Bromide contains a quinuclidine core with substituted aromatic rings plus a bromide counterion for charge balance, contributing to its physicochemical behavior in water and organic solvents. Its crystalline nature stands out, with some samples presenting as thin flakes under magnification, but mostly it comes as a softly packed powder with a dry texture. The compound won’t flow like a liquid, nor will it melt or degrade under standard room temperatures. Purity levels matter: as impurities rise, color and texture might shift, which impacts what users see under lab conditions. Specific gravity tests line up near 1.3 g/cm3. Boiling and melting points don’t commonly factor into typical work with this material, since it’s used well below temperatures that could trigger such changes.
In commercial supply chains, Umeclidinium Bromide usually comes as powder or granules, packed in sealed polyethylene pouches or glass bottles to guard against moisture intrusion and contamination during transit. Bulk buyers might spot pelletized or flake forms, designed for use in high-volume pharmaceutical processes. Shipment frequently uses airtight drums, with clear labeling to identify hazard and safety data, as well as detailed batch specifications. Laboratory stocks favor small glass vials, capped tightly to stop water absorption that can alter the material’s weight and potency. A typical container might hold anywhere from 10 grams up to several kilograms, depending on the customer—ranging from university research labs to international pharmaceutical manufacturers.
Regulatory clearance paves the way for every commercial batch, with the compound generally cataloged under HS Code 29349990, identifying it among other organic compounds outside standard pharmaceutical categories. Safe transport and handling protocols stem from its moderate classification—a non-flammable, low-risk chemical in day-to-day handling—yet standard chemical hygiene guidelines always apply. Users need proper labeling and transport, following both international and national regulations, as mistakes can lead to embargoes or fines at customs. Importers and exporters stick closely to these code distinctions, as tariff and duty rates can change based on how authorities classify active pharmaceutical ingredients.
Despite its widespread use, conscious handling of Umeclidinium Bromide always matters, especially in lab or production setups. Direct contact with skin or eyes won’t cause harm in the same way corrosives or acutely toxic chemicals might, yet safety data sheets warn about repeated inhalation or accidental ingestion over time, which could introduce harmful effects, particularly before dilution or processing into medicine. Proper use of nitrile gloves, goggles, and dust masks, especially in powder-handling environments, prevents accidental contact or inhalation. Work with this chemical should take place in well-ventilated labs, supported by access to Material Safety Data Sheets that specify all known or suspected health effects. Waste management involves secure containment and disposal through chemical waste services, never simple trashing or washing down the drain.
Every gram of Umeclidinium Bromide starts out as raw materials sourced and processed under regulated conditions. Manufacturers keep purity standards at pharmaceutical grade, filtering out anything that could degrade the safety or efficacy of finished inhalable medications. Starting with basic organic precursors, each production run includes stringent quality analysis, using modern chromatography and mass spectrometry to check for residual solvents and side-products that might alter the main material. The broader industry links this compound to a range of finished goods, notably as an active ingredient in inhalers. Stringent quality standards extend all the way down to labeling: each production lot documented, each batch certified for compliance with industry and health authority standards before shipping.
Umeclidinium Bromide does not degrade readily under room temperature if kept dry and protected from bright light, offering a shelf life usually extending past two years in original packaging. Producers typically include reinforced seals and desiccant packs inside bulk bottles to fight off humidity, which can clump powder or reduce its weight fraction when exposed over weeks or months. Storage calls for well-sealed containers in cool, dry rooms; those facilities usually run constant monitoring for temperature and humidity, since moisture build-up leads to physical changes or even low-level decomposition. Careless storage—broken bottles, open bags—quickly leads to contamination, risking safety and regulatory non-compliance.
Managing the growing demand for Umeclidinium Bromide without compromising quality, supply security, or safe handling gets trickier as more markets approve new respiratory therapies. Past supply chain hiccups, caused by fluctuations in global boron and organic precursor availability, underline the need for robust sourcing strategies. Full traceability matters not just for compliance but for consumer safety. Environmental concerns about waste and solvent disposal also press chemical manufacturers to introduce cleaner manufacturing technology, with solvent recycling and target purity management at the forefront. Industry-wide collaboration, reinforced by regulatory authorities sharing best practices, promises steady improvements. As countries tighten up scrutiny on hazardous chemicals, open reporting and proactive risk management—focusing on safety training and regular review of emerging toxicological data—will help maintain high standards in how Umeclidinium Bromide touches every point from raw material to finished medication.
